Question 1

What is UroGen Pharma?

Accepted Answer

UroGen Pharma is a Company.

Question 2

How often does UroGen Pharma appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was UroGen Pharma first tracked by Ergen?

Accepted Answer

First tracked on Jun 05, 2025.

Question 4

When was UroGen Pharma last mentioned in news?

Accepted Answer

Last active on Jul 08, 2026.

Question 5

What is UroGen Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 2 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is UroGen Pharma in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving UroGen Pharma?

Accepted Answer

UroGen Pharma CMO Sells Stock (Jun 14, 2026, 6 articles).

Question 8

How did the "UroGen Pharma CMO Sells Stock" event impact UroGen Pharma?

Accepted Answer

UroGen Pharma Ltd. is the company whose stock was sold by its CMO. The company is developing and commercializing specialty therapeutics for urothelial cancers. The insider sales could be perceived negatively by investors, though the company's financial performance and pipeline show positive developments.

Question 9

How did the "UroGen FDA IND clearance for UGN-501" event impact UroGen Pharma?

Accepted Answer

UroGen received FDA clearance to begin Phase 1 trials for UGN-501, a key pipeline asset. The event supports its oncology strategy but is early-stage.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.